Evidence Clinical and Pharmaceutical Research

Evidence Clinical and Pharmaceutical Research (Evidence CPR) is a full-service Contract Research Organization (CRO) headquartered in Saint Petersburg, Russia. Established in 2003, the company provides a broad range of clinical development services, including Phase I-IV trial management, regulatory consulting, and pharmacovigilance. It primarily serves the pharmaceutical and biotechnology industries with a focus on Russia, the Commonwealth of Independent States (CIS), and Eastern Europe. The company is known for its expertise in navigating complex local regulatory environments and delivering high-quality clinical data. In 2022, Evidence CPR was acquired by Labcorp to bolster its regional clinical trial capabilities. Following the 2023 spin-off of Labcorp's clinical development unit, the company now operates under the Fortrea brand.